Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Hematopoiesis

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...

Overview of Hematopoiesis

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...

Production of Formed Elements

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...

Source And Potency Of Stem Cells

Source And Potency Of Stem Cells

Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Regarding "Misleading Conclusions Die Hard: Citing Flawed Research for Personal Agendas".

Current sports medicine reports·2026

Same author

Sickle Cell Trait, Inequity, and the Need for Change.

The New England journal of medicine·2024

Same author

In reply: Considering the reporting of race in the transfusion medicine literature.

Transfusion·2024

Same author

Current advances in 2024: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee.

Transfusion·2024

Same author

High CD34-positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft-versus-host disease or mortality.

Transfusion·2024

Same author

Examining Injustices: Transfusion Medicine and Race.

Transfusion medicine reviews·2024

Same journal

Transplanted Cerebrospinal Fluid-Contacting Neurons Alleviate Spasticity Following Spinal Cord Injury in Mice.

Current stem cell research & therapy·2026

Same journal

Ear Cartilage Reconstruction: From Regenerative Medicine to Reconstructive Surgery.

Current stem cell research & therapy·2026

Same journal

Application of Wharton's Jelly Derived from Human Umbilical Cord in Tissue Engineering.

Current stem cell research & therapy·2026

Same journal

Gestational Age, Maternal Age, and Culture Dynamics Shape the Pluripotency Marker Profile of Primary Amniocytes: Insights for Stem Cell Biology and Regenerative Applications.

Current stem cell research & therapy·2026

Same journal

Outcomes of Chimeric Antigen Receptor T-cell (CAR-T) Cell Therapy in Hematological Malignancies - A Systematic Review and Meta Analysis.

Current stem cell research & therapy·2026

Same journal

Preface.

Current stem cell research & therapy·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells

Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells

Published on: February 25, 2007

Hematopoietic stem cells: source matters.

Richard L Haspel¹, Kenneth B Miller

¹Deaconess Medical Center, Department of Pathology, 330 Brookline Avenue, Yamins 309, Boston, MA 02215, USA. rhaspel@bidmc.harvard.edu

Current Stem Cell Research & Therapy

|December 17, 2008

Summary

This summary is machine-generated.

Hematopoietic stem cell transplantation uses bone marrow, peripheral blood, or cord blood. Each source offers unique benefits and drawbacks regarding collection, cell content, and transplant outcomes, influencing engraftment and graft-versus-host disease.

More Related Videos

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells

Published on: May 19, 2023

Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors

Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors

Published on: July 8, 2012

Related Experiment Videos

Last Updated: Jun 27, 2026

Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells

Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells

Published on: February 25, 2007

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells

Published on: May 19, 2023

Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors

Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors

Published on: July 8, 2012

Area of Science:

Hematology
Transplantation Immunology
Stem Cell Biology

Background:

Allogeneic hematopoietic stem cell transplantation (HSCT) relies on stem cells from various sources.
Bone marrow, peripheral blood, and cord blood are primary sources, each with distinct characteristics.
Understanding these differences is crucial for optimizing HSCT outcomes.

Purpose of the Study:

To review the advantages and disadvantages of different hematopoietic stem cell sources for allogeneic transplantation.
To compare outcomes associated with bone marrow, peripheral blood, and cord blood stem cells.
To identify areas for future research in stem cell source selection.

Main Methods:

This is a review article, synthesizing existing literature on stem cell sources for HSCT.
Comparative analysis of collection methods, cellular content, and transplant outcomes.
Discussion of graft-versus-host disease (GvHD) and engraftment kinetics.

Main Results:

Peripheral blood stem cells (PBSCs) offer faster engraftment and potential survival benefits in advanced disease compared to bone marrow, but may increase chronic GvHD.
Cord blood stem cells (CBSCs) are easily collected and provide HLA matching flexibility but have lower stem cell doses, leading to slower engraftment.
Bone marrow (BM) remains a viable source, with specific considerations for collection and outcomes.

Conclusions:

The choice of stem cell source in allogeneic HSCT involves a trade-off between engraftment speed, GvHD risk, and collection ease.
Further research is needed to optimize the use of each stem cell source and mitigate their respective disadvantages.
Tailoring stem cell source selection to individual patient and disease characteristics is paramount.